Biotechnology Stocks
| # | Últimos 7 días | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 3674 |  KRRO Korro Bio, Inc. - Common Stock | 10.58 USD | +0.86% | +6.87% | -17.34% | -72.80% | 155.80 M USD | ||
| 3676 |  MOLN Molecular Partners AG - American Depositary Shares | 3.81 USD | +0.79% | -2.81% | -8.85% | +3.53% | 153.83 M USD | ||
| 3677 |  NERV Minerva Neurosciences, Inc - Common Stock | 3.22 USD | -1.53% | -2.13% | -21.46% | +33.06% | 153.75 M USD | ||
| 3682 |  ABOS Acumen Pharmaceuticals, Inc. - Common Stock | 2.10 USD | 0.00% | 0.00% | -24.73% | -8.30% | 151.87 M USD | ||
| 3695 |  CDXS Codexis, Inc. - Common Stock | 1.36 USD | -3.55% | -2.16% | -4.23% | -51.43% | 148.93 M USD | ||
| 3700 |  VYGR Voyager Therapeutics, Inc. - Common Stock | 2.37 USD | -4.05% | -12.87% | -25.94% | -49.03% | 146.03 M USD | ||
| 3706 |  ARMP Armata Pharmaceuticals, Inc. Common Stock | 3.85 USD | 0.00% | +11.92% | -30.51% | -52.88% | 143.15 M USD | ||
| 3708 |  AVXL Anavex Life Sciences Corp. - Common Stock | 1.54 USD | +0.65% | -18.09% | -43.17% | -83.70% | 142.75 M USD | ||
| 3713 |  RNA Atrium Therapeutics, Inc. - Common Stock | 8.26 USD | +4.16% | +0.49% | -20.88% | -88.26% | 141.29 M USD | ||
| 3724 |  OTLK Outlook Therapeutics, Inc. - Common Stock | 0.56 USD | -5.08% | -5.08% | -11.11% | +36.59% | 136.33 M USD | ||
| 3725 |  IPHA Innate Pharma S.A. - American Depositary Shares | 1.48 USD | -2.63% | -5.13% | -22.51% | -25.25% | 138.70 M USD | ||
| 3737 |  TLSA Tiziana Life Sciences Ltd - Common Shares | 1.13 USD | +2.73% | 0.00% | +17.71% | -47.69% | 136.17 M USD | ||
| 3750 |  ADAG Adagene Inc - ADS, each representing 1.25 | 2.78 USD | -1.07% | -6.08% | -21.25% | +40.40% | 131.73 M USD | ||
| 3754 |  SPRB Spruce Biosciences, Inc. - Common Stock | 45.54 USD | +2.57% | +3.20% | -18.11% | -74.38% | 130.88 M USD | ||
| 3762 |  NRXP NRX Pharmaceuticals, Inc. - Common Stock | 2.89 USD | -0.34% | -0.34% | -13.73% | +62.36% | 125.12 M USD | ||
| 3763 |  HUMA Humacyte, Inc. - Common Stock | 0.45 USD | -4.26% | -11.76% | -22.41% | -72.39% | 125.01 M USD | ||
| 3765 |  TNXP Tonix Pharmaceuticals Holding Corp. - Common Stock | 7.28 USD | -3.58% | -21.72% | -41.85% | -51.50% | 124.86 M USD | ||
| 3771 |  HURA TuHURA Biosciences, Inc. - Common Stock | 1.93 USD | -2.53% | -3.02% | -3.98% | -24.90% | 122.99 M USD | ||
| 3775 |  CBUS Cibus, Inc. - Class A Common Stock | 1.59 USD | -1.85% | -2.45% | +1.92% | +5.30% | 121.52 M USD | ||
| 3776 |  TNYA Tenaya Therapeutics, Inc. - Common Stock | 0.54 USD | +1.89% | -5.26% | -18.18% | -75.68% | 121.08 M USD |
Noticias Biotechnology Stocks
El fármaco de Pharvaris para el angioedema hereditario muestra alivio más rápido
Raymond James inicia cobertura de Kymera Therapeutics con Mejor Rendimiento
Raymond James inicia cobertura de Nektar con calificación de rendimiento de mercado
Palisade Bio inicia cobertura con Mejor Rendimiento según Raymond James
Raymond James reitera su calificación de Liquidia en medio de presentaciones legales
Tenax Therapeutics pausa temporalmente la inscripción en el ensayo LEVEL-2 de TNX-103 para modificar los criterios; solicita reunión con la FDA
Ginkgo Bioworks apoyará a los X-Labs de la NSF con acceso a su laboratorio
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |